Yourgene Health (YGEN)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 0.39p
   
  • Change Today:
      0.000p
  • 52 Week High: 10.00
  • 52 Week Low: 0.31
  • Currency: UK Pounds
  • Shares Issued: 3,176.96m
  • Volume: 11,090,010
  • Market Cap: £12.23m

YGEN Overview

Yourgene Health is a leading integrated technologies and services business, enabling the delivery of genomic medicine. The group works in partnership with global leaders in DNA technology to advance diagnostic science.

1 Day Chart (02-02-2023)

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -6.8% -27.4%
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 0.3 0.6
Pr/Book 0.4  
Latest F'cast
Revenue 105.4% -46.6%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

YGEN Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Mar-18 6.15 (9.54) (3.00)p n/a n/a n/a n/a 0.0%
31-Mar-19 8.88 3.39 0.90p 13.9 n/a n/a n/a 0.0%
31-Mar-20 16.61 (3.38) (0.40)p n/a n/a n/a n/a 0.0%
31-Mar-21 18.29 (12.00) (1.80)p n/a n/a n/a n/a 0.0%
31-Mar-22 37.56 (3.19) (0.30)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

YGEN Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Mar-23 20.05 (5.50) (0.57)p n/a n/a n/a n/a 0.0%
31-Mar-24 22.55 (2.60) (0.18)p n/a n/a n/a n/a 0.0%
31-Mar-25 25.90 (1.60) (0.11)p n/a n/a n/a n/a 0.0%

Copyright © 2023 FactSet Research Systems Inc. All rights reserved.

YGEN Company Announcements

Holding(s) in Company 27-Jan-2023 07:00 RNS
Directorate Change 25-Jan-2023 07:00 RNS
Director/PDMR Shareholding 18-Jan-2023 12:07 RNS

YGEN ShareCast News

Total revenues tumble as Yourgene winds down Cov... 03-Nov-2022 ShareCast
Yourgene gets UK approval for 'Clarigene' Covid-... 17-Feb-2022 ShareCast
Yourgene Health sees FY revenue, underlying EBIT... 17-Jan-2022 ShareCast

YGEN Top Newspaper Links

SMALL CAP IDEAS: Premaitha Health builds foundat... 16-Dec-2014 Daily Mail
Less Scottish companies taking AIM to hit targets 16-May-2007 The Scotsman
Scottish firms lack AIM appetite 05-Jan-2007 The Scotsman

Latest YGEN Director Deals

Traded Action Notifier PriceAmountValue
10-Jan-23 Buy Bill Chang 0.31p 2,000,000 £6,200.00
10-Jan-23 Buy Bill Chang 0.32p 1,000,000 £3,200.00
10-Jan-23 Buy Bill Chang 0.31p 1,000,000 £3,100.00

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

YGEN Market Data

Currency UK Pounds
Share Price 0.39p
Change Today 0.000p
% Change 0.00 %
52 Week High 10.00
52 Week Low 0.31
Volume 11,090,010
Shares Issued 3,176.96m
Market Cap £12.23m

YGEN Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
68.96% above the market average68.96% above the market average68.96% above the market average68.96% above the market average68.96% above the market average
72.41% above the sector average72.41% above the sector average72.41% above the sector average72.41% above the sector average72.41% above the sector average
Price Trend
99.68% below the market average99.68% below the market average99.68% below the market average99.68% below the market average99.68% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Income Not Available
Growth
58.01% above the market average58.01% above the market average58.01% above the market average58.01% above the market average58.01% above the market average
80.00% above the sector average80.00% above the sector average80.00% above the sector average80.00% above the sector average80.00% above the sector average

What The Brokers Say

Strong Buy 0
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 2
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

YGEN Dividends

No dividends found

Trades for 02-Feb-2023

Time Volume / Share Price
15:46 76,491 @ 0.39p
15:28 2,608 @ 0.38p
15:02 1,000,000 @ 0.39p
14:45 262,825 @ 0.38p
14:31 14,250 @ 0.38p

YGEN Key Personnel

CFO Barry Kenneth Hextall
CEO Lyn Rees

Top of Page